Biomarkers predictive of therapeutic responsiveness to chimeric antigen receptor therapy and uses thereof
US10774388B2 · kind B2 · utility
1Cited by
43References
31Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 7, 2015 |
| Grant date | Sep 15, 2020 |
| Priority date | — |
| Expiry date | Feb 25, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cancer biomarkers and methods of using them are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.